Randomized Controlled Trials and Challenge Trials: Design and Criterion for Validity

Zoonoses and Public Health

Volumn 61, Issue SUPPL1, 2014, Pages 18-27

  Sargeant, J M ^a,b   Kelton, D F ^a,b   O'Connor, A M ^c  

^a UNIVERSITY OF GUELPH   (Canada)

^b UNIVERSITY OF GUELPH   (Canada)

^c IOWA STATE UNIVERSITY   (United States)

Author keywords

Challenge trials; Randomized controlled trials; Study design; Validity; Veterinary

Indexed keywords

ANTIBIOTIC AGENT; VACCINE;

AGRICULTURE; COMORBIDITY; CRITERION RELATED VALIDITY; EXTERNAL VALIDITY; FOLLOW UP; GOLD STANDARD; HUMAN; INFECTION; INTENTION TO TREAT ANALYSIS; INTERNAL VALIDITY; MANDATORY REPORTING; MORBIDITY; MORTALITY; NONHUMAN; OUTCOME ASSESSMENT; POTENTIAL DIFFERENCE; PRACTICE GUIDELINE; PRIORITY JOURNAL; QUALITY CONTROL; RANDOMIZATION; RANDOMIZED CONTROLLED TRIAL (TOPIC); RESPIRATORY TRACT DISEASE; REVIEW; SAMPLE SIZE; STATISTICAL ANALYSIS; SYSTEMATIC ERROR; SYSTEMATIC REVIEW (TOPIC); VETERINARY MEDICINE; WRITING; ANIMAL; CLINICAL TRIAL (TOPIC); FOOD SAFETY; LITERATURE; LIVESTOCK; META ANALYSIS (TOPIC); METHODOLOGY; REPRODUCIBILITY; VALIDATION STUDY;

AGRICULTURE; ANIMALS; CLINICAL TRIALS AS TOPIC; FOOD SAFETY; LIVESTOCK; META-ANALYSIS AS TOPIC; RANDOMIZED CONTROLLED TRIALS AS TOPIC; REPRODUCIBILITY OF RESULTS; RESEARCH DESIGN; REVIEW LITERATURE AS TOPIC; VALIDATION STUDIES AS TOPIC; VETERINARY MEDICINE;

EID: 84902006233     PISSN: 18631959     EISSN: 18632378     Source Type: Journal    
DOI: 10.1111/zph.12126     Document Type: Review

References (45)

1. Altman, D. G., 1980: Statistics and ethics in medical research: III How large a sample? BMJ 281, 1136-1138.
2. Altman, D. G., 1985: Comparability of Randomised Groups. J. R. Stat. Soc. Series D. (The Statist.) 34, 125-136.
3. Altman, D. G., 1991: Randomisation: essential for reducing bias. BMJ 302, 1481-1482.
4. Altman, D. G., and J. M. Bland, 1995: Absence of evidence is not evidence of absence. BMJ 311, 485.
5. Begg, C. B., 1990: Suspended judgment. Significance tests of covariate imbalance in clinical trials. Control. Clin. Trials 11, 223-225.
6. Begg, C., M. Cho, S. Eastwood, R. Horton, D. Moher, I. Olkin, R. Pitkin, D. Rennie, K. F. Schulz, D. Simel, and D. F. Stroup, 1996: Improving the quality of reporting of randomized controlled trials. The CONSORT statement. JAMA 276, 637-639.
7. Campbell, M. K., D. R. Elbourne, and D. G. Altman, 2004: CONSORT statement: extension to cluster randomised trials. BMJ 328, 702-708.
8. Clancy, M. J., 2002: Overview of research designs. Emerg. Med. J. 19, 546-549.
9. Cohen, S., W. J. Doyle, D. P. Skoner, B. S. Rabin, and J. M. Gwaltney Jr, 1997: Social ties and susceptibility to the common cold. JAMA 277, 1940-1944.
10. CONSORT, 2010: CONSORT statement. Available at: http://www.consort-statement.org/ (Accessed on 09 April 2013).
11. Devereaux, P. J., B. J. Manns, W. A. Ghali, M. Bhandari, V. M. Montori, H. J. Schunemann, A. X. Garg, J. W. Busse, W. A. Heels-Ansdell, B. J. Manns, and G. H. Guyatt, 2001: Physician interpretations and textbook definitions of blinding terminology in randomized controlled trials. JAMA 285, 2000-2003.
12. Devereaux, P. J., P. T. Choi, S. El-Dika, M. Bhandari, V. M. Montori, H. J. Schunemann, A. X. Garg, J. W. Busse, D. Heels-Ansdell, W. A. Ghali, B. J. Manns, and G. H. Guyatt, 2004: An observational study found that authors of randomized controlled trials frequently use concealment of randomization and blinding, despite the failure to report these methods. J. Clin. Epidemiol. 57, 1232-1236.
13. Devereaux, P. J., M. Bhandari, V. M. Montori, B. J. Manns, W. A. Ghali and G. H. Guyatt 2005: Double blind, you are the weakest link-goodbye!. Equine Vet. J. 37, 557-558.
14. Dohoo, I., W. Martin, and H. Stryhn, 2010: Veterinary Epidemiologic Research. 2nd edn. VER Inc., Charlettetown, PEI.
15. Freedman, B., 1987: Equipoise and the ethics of clinical research. N. Engl. J. Med. 317, 141-145.
16. Giuffrida, M. A., K. A. Agnello, and D. C. Brown, 2012: Blinding terminology used in reports of randomized controlled trials involving dogs and cats. J. Am. Vet. Med. Assoc. 241, 1221-1226.
17. Glasser, S. P., and G. Howard, 2006: Clinical trial design issues: at least 10 things you should look for in clinical trials. J. Clin. Pharmacol. 46, 1106-1115.
18. Hills, M., and P. Armitage, 1979: The two-period cross-over clinical trial. Br. J. Clin. Pharmacol. 8, 7-20.
19. Johnson, P. D., and D. G. Besselsen, 2002: Experimental design and statistics in biomedical research practical aspects of experimental design in animal research. ILAR J. 43, 202-206.
20. Juni, P., D. G. Altman, and M. Egger, 2001: Systematic reviews in health care: assessing the quality of controlled clinical trials. BMJ 323, 42-46.
21. Kingsley, G. H., B. Khoshaba, C. M. Smith, E. H. Choy, and D. L. Scott, 2005: Are clinical trials in rheumatoid arthritis generalizable to routine practice? A re-evaluation of trial entry criteria. Rheumatology (Oxford) 44, 629-632.
22. Kjaergard, L. L., J. Villumsen, and C. Gluud, 2001: Reported methodologic quality and discrepancies between large and small randomized trials in meta-analyses. Ann. Intern. Med. 135, 982-989.
23. Lachin, J. L., 2000: Statistical considerations in the intent-to-treat principle. Control. Clin. Trials 21, 167-189.
24. Lilford, R. J., and J. Jackson, 1995: Equipoise and the ethics of randomization. J. R. Soc. Med. 88, 552-559.
25. Lund, E. M., K. M. James, and J. D. Neaton, 1994: Clinical trial design: veterinary perspectives. J. Vet. Intern. Med. 8, 317-322.
26. Moher, D., K. F. Schulz, and D. Altman, 2001: The CONSORT statement: revised recommendations for improving the quality of reports of parallel-group randomized trials. JAMA 285, 1987-1991.
27. Moher, D., S. Hopewll, K. F. Schulz, V. Montori, P. C. Gotzsche, P. J. Devereaux, D. Elbourne, M. Egger, and D. G. Altman, 2010: CONSORT 2010 Explanation and Elaboration: updated guidelines for reporting parallel group randomised trials. J. Clin. Epidemiol. 63, e1-e37.
28. Morgan, K. L., and D. B. Rubin, 2012: Rerandomization to improve covariate balance in experiments. Ann. Stats. 40, 1263-1282.
29. O'Connor, A. M., J. M. Sargeant, I. A. Gardner, J. S. Dickson, M. E. Torrence, C. E. Dewey, I. R. Dohoo, R. B. Evans, J. T. Gray, M. Greiner, G. Keefe, S. L. Lefebvre, P. S. Morley, A. Ramirez, W. Sischo, D. R. Smith, K. Snedeker, J. Sofos, M. P. Ward, and R. Wills, 2010: The REFLECT Statement: methods and processes of creating reporting guidelines for randomized controlled trials for livestock and food safety by modifying the CONSORT statement. Zoonoses Public Health 57, 95-104.
30. Petrie, A., and P. Watson, 2013: Statistics for Veterinary and Animal Science. 3rd edn. Wiley-Blackwell, Oxford, UK.
31. Piantadosi, S., 2005: Clinical Trials: A Methodological Perspective. 2nd edn. John Wiley and Sons, Inc., Hoboken, NJ.
32. Pocock, S. J., 1998: Clinical Trials: A Practical Approach. John Wiley and Sons Ltd, Midsomer Norton, Somerset.
33. Sargeant, J. M., M. E. Torrence, A. Rajic, A. M. O'Connor, and J. Williams, 2006: Methodological quality assessment of review articles evaluating interventions to improve microbial food safety. Foodborne Pathog. Dis. 3, 447-456.
34. Sargeant, J. M., R. Elgie, J. Valcour, J. Saint-Onge, A. Thompson, P. Marcynuk, and K. Snedeker, 2009a: Methodological quality and completeness of reporting in clinical trials conducted in livestock species. Prev. Vet. Med. 91, 107-115.
35. Sargeant, J. M., J. Saint-Onge, J. Valcour, A. Thompson, R. Elgie, K. Snedeker, and P. Marcynuk, 2009b: Quality of reporting in clinical trials of preharvest food safety interventions and associations with treatment effect. Foodborne Pathog. Dis. 6, 989-999.
36. Sargeant, J. M., A. M. O'Connor, I. A. Gardner, J. S. Dickson, M. E. Torrence, I. R. Dohoo, S. L. Lefebvre, P. S. Morley, A. Ramirez, and K. Snedeker, 2010a: The REFLECT statement: reporting guidelines for randomized controlled trials in livestock and food safety: explanation and elaboration. Zoonoses Public Health 57, 105-136.
37. Sargeant, J. M., A. Thompson, J. Valcour, R. Elgie, P. Saint-Onge, P. Marcynuk, and K. Snedeker, 2010b: Quality of reporting of clinical trials of dogs and cats and associations with treatment effects. J. Vet. Intern. Med. 24, 44-50.
38. Schulz, K. F., 1995: Subverting randomization in controlled trials. JAMA 274, 1456-1458.
39. Schulz, K. F., and D. A. Grimes, 2002: Generation of allocation sequences in randomised trials: chance, not choice. Lancet 359, 515-519.
40. Schulz, K. F., and D. A. Grimes, 2005: Sample size calculations in randomised trials: mandatory and mystical. Lancet 365, 1348-1353.
41. Schulz, K. F., D. G. Alman, D. Moher, and for the CONSORT group, 2010: CONSORT 2010 Statement: Updated guidelines for reporting parallel group randomized trials. J. Clin. Epidemiol. 63, 834-840.
42. Seder, R. A., L. J. Chang, M. E. Enama, K. L. Zephir, U. N Sarwar, I. J. Gordon, L. A. Holman, E. R. James, P. F. Billingsley, A. Gunasekera, A. Richman, S. Chakravarty, A. Manoj, S. Velmurugan, M. Li, A. J. Ruben, T. Li, A. G. Eappen, R. E. Stafford, S. H. Plummer, C. S. Hendel, L. Novik, P. J. Costner, F. H. Mendoza, J. G. Saunders, M. C. Nason, J. H. Richardson, J. Murphy, S. A. Davidson, T. L. Richie, M. Sedegah, A. Sutamihardja, G. A. Fahle, K. E. Lyke, M. B. Laurens, M. Roederer, K. Tewari, J. E. Epstein, B. K. Sim, J. E. Ledgerwood, B. S. Graham, and S. L. Hoffman, and the VRC 312 Study Team. 2013: Protection against malaria by intravenous immunization with the nonreplicating sporozoite vaccine. Science 341: 1359-1365.
43. Suarez-Almazor, M. E., 2002: In quest of the holy grail: efficacy versus effectiveness in rheumatoid arthritis. J. Rheumatol. 29, 209-211.
44. Weijer, C., S. H. Shapiro, K. C. Glass, and M. W. Enkin, 2000: For and against - Clinical equipoise and not the uncertainty principle is the moral underpinning of the randomised controlled trial. Br. Med. J. 321, 756-758.
45. Wolfe, F., 2005: Why results of clinical trials and observational studies of anti-TNF therapy differ: methodological and interpretive issues. Ann. Rheum. Dis. 63, ii13-ii17.